FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy Read more
Tom Parke to lead a workshop on the new FDA draft guidance on Adaptive designs during the 11th Annual Conference Read more
Exelixis Announces FDA Approval of CABOMETYX (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma Read more
Key Pharmaceuticals Ltd to lead a workshop on Parallel Trade & Brexit during the 13th Annual Parallel Trade Conference Read more
Puma and Knight Enter into Exclusive License Agreement to Commercialize NERLYNX (neratinib) in Canada Read more
Chinese API Market Growing Strongly, CPhI China Assisting Enterprises with the Transformation, Innovation, and Comprehensive Upgrading Read more